
Cannabis-based product Sativex should be reclassified as a Schedule 2 Controlled Drug, the Advisory Council on the Misuse of Drugs has recommended in a letter to crime prevention minister James Brokenshire (17 January 2011).
To read the full story click here.
Extract taken from PJ Online